Group One Trading
TCRR

Group One Trading’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Group One Trading’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,800
Closed -$29.7K – 8455
2023
Q1 		$29.7K Sell
19,800
-51,600
-72% -$69.5K ﹤0.01% 5245
2022
Q4 		$71.1K Sell
71,400
-7,800
-10% -$10.5K ﹤0.01% 4736
2022
Q3 		$143K Buy
79,200
+18,400
+30% +$53.4K ﹤0.01% 4455
2022
Q2 		$176K Buy
60,800
+60,600
+30,300% +$150K ﹤0.01% 4422
2022
Q1 		$1K Sell
200
-4,800
-96% -$15.1K ﹤0.01% 7919
2021
Q4 		$23K Sell
5,000
-25,800
-84% -$161K ﹤0.01% 6903
2021
Q3 		$262K Buy
30,800
+29,200
+1,825% +$413K ﹤0.01% 4902
2021
Q2 		$26K Buy
1,600
+600
+60% +$12.1K ﹤0.01% 7044
2021
Q1 		$22K Sell
1,000
-4,500
-82% -$123K ﹤0.01% 6734
2020
Q4 		$170K Buy
+5,500
New +$139K ﹤0.01% 4184

Group One Trading's TCRR Position: Q2 2023 in Review

Group One Trading sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q2 2023, closing a stake of 800 shares — an estimated $1.2K sold.

Group One Trading first reported a position in TCRR in Q1 2022 and held it in 3 quarters. The position peaked at $2K in Q2 2022. 0 funds tracked by Wall St. Rank hold TCRR as of Q2 2023.

  • Group One Trading reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Group One Trading sold 800 TCR2 Therapeutics Inc. Common Stock shares in Q2 2023, an estimated $1.2K.
  • Group One Trading first reported a position in TCR2 Therapeutics Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Group One Trading's TCR2 Therapeutics Inc. Common Stock position peaked at $2K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q2 2023.

Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.